Shanghai MicroPort MedBot (Group) Co., Ltd.

Equities

2252

CNE100004QP1

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 04:08:20 2024-04-16 am EDT 5-day change 1st Jan Change
11.68 HKD -4.26% Intraday chart for Shanghai MicroPort MedBot (Group) Co., Ltd. -8.18% -43.98%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai Microport Medbot Co., Ltd. Provides Group Earnings Guidance for the Year Ended December 31, 2023 CI
Shanghai MicroPort MedBot Co., Ltd. Approves Board Elections CI
China Approves Surgical Robot Developed by Microport MedBot-Robocath JV MT
Shanghai Microport MedBot Gets Thumbs Up to Launch Toumai Surgical Robot MT
Shanghai Microport Medbot Co., Ltd. Announces Toumai Laparoscopic Surgical Robot Obtains Approval from the National Medical Products Administration of China for Multidisciplinary Registration CI
China Approves Launch of MedBot's Orthopedic Surgical Robot MT
Shanghai MicroPort MedBot's Skywalker Hip and Knee Arthroplast Surgical Robot Obtains Launch Approval from National Medical Products Administration of China CI
Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
MedBot's Orthopedic Surgical Robot Gets Nod to Enter Australian Market MT
MedBot Obtains European Union's CE Mark for Laparoscope MT
Shanghai Microport Medbot's Prostate Biopsy System Wins Regulatory Nod to Launch MT
Shanghai MicroPort MedBot Co., Ltd. Announces Skywalker Orthopedic Surgical Robot Obtained the ANVISA Certification in Brazil CI
Sunac China working to secure funding to complete projects, chairman says RE
Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Sunac China Holdings to Publish US-Dollar Bond Restructuring Program by March-End MT
Shanghai MicroPort MedBot Expects 850% Surge in 2022 Revenue; Shares Slip 9% MT
Shanghai MicroPort MedBot Co., Ltd. Provides Unaudited Earnings Guidance for the Year Ended 31 December 2022 CI
Shanghai Microport Medbot Co., Ltd. and Microport Scientific Corporation Enter into the Sales Framework Agreement CI
Shanghai MicroPort's Total Knee System Obtains CE Mark in Europe MT
Certain H Shares of Shanghai MicroPort MedBot Co., Ltd. are subject to a Lock-Up Agreement Ending on 1-NOV-2022. CI
Shanghai MicroPort MedBot Widens Loss in H1 MT
Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shanghai MicroPort MedBot Co., Ltd. Announces Address Change CI
Shanghai MicroPort MedBot's Surgical Robot Gets US FDA Approval; Shares Down 5% MT
Chart Shanghai MicroPort MedBot (Group) Co., Ltd.
More charts
Shanghai MicroPort Medical Robot Group Co Ltd is a company engaged in the development of surgical instruments. The Company's main business is the design, development and commercialization of innovative surgical robots. The Company's products include Toumai Laparoscopic Surgical Robot, DFVision 3D Electronic Laparoscope and Honghu Orthopedic Surgical Robot. The Company's surgical robots are used in multiple minimally invasive surgery fields, including endoscopic surgery, orthopedic surgery, pan-vascular surgery, natural cavity surgery and percutaneous puncture surgery. In addition, the Company also provides education and training services for its surgical robot MedBot.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.28 CNY
Average target price
21.26 CNY
Spread / Average Target
+88.48%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2252 Stock
  4. News Shanghai MicroPort MedBot (Group) Co., Ltd.
  5. MicroPort MedBot Shares Slide Nearly 8% in Hong Kong Debut